Developer docs
API playgroundTry for free, no card

Search company profiles

Abaxis

Full company profile

uuid003c7iy

Namestring
Abaxis
Legal namestring
Abaxis, Inc.
Websiteurl
abaxis.com
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Abaxis develops, manufactures, and distributes point-of-care blood chemistry diagnostic systems, with the Piccolo Xpress analyzer as its flagship product. The platform combines spectrophotometry and centrifugal analysis to deliver multi-chemistry panel results from approximately 100 microliters of whole blood, serum, or plasma in roughly 12 minutes. At its core is a single-use, self-contained reagent disc that holds all reagents and diluent for a complete panel, paired with an integrated intelligent Quality Control (iQC) system that automatically validates each run. The company markets 17 reagent panels covering 31 tests spanning general and critical chemistry (basic metabolic, comprehensive metabolic, lipid, liver, kidney, electrolyte, and specialty panels), eleven of which are CLIA-waived for use outside traditional laboratory settings.

Abaxis serves a broad healthcare customer base across six verticals: primary care practices, urgent care centers, hospitals and integrated delivery networks, specialty care providers, government and military operations, and clinical research organizations. The company has historically operated an asset-light commercial model, selling Piccolo Xpress analyzers and reagent disc consumables exclusively through a global network of authorized distributors — including Abbott Point of Care as primary US distributor, Sysmex across multiple European markets, and country-specific distributors spanning North America, Europe, Asia-Pacific, the Middle East, and Africa. Revenue mechanics combine upfront analyzer hardware placement with recurring consumables revenue, supported by reimbursement from private insurers and government healthcare programs in multi-payer markets.

Abaxis was acquired by Zoetis in 2018 and now operates as a wholly-owned subsidiary within Zoetis's diagnostics business, with veterinary products redirected to ZoetisUS.com/dx while the human point-of-care franchise continues under the Abaxis brand through its existing distributor network. The firm was founded in 1989 and is headquartered in Union City, California, with a regional office in Garching, Germany. Current ownership is private; the company previously traded on NASDAQ under ABAX prior to the Zoetis acquisition.

Short descriptiontext

Abaxis (Zoetis subsidiary) manufactures the Piccolo Xpress point-of-care blood chemistry analyzer and proprietary single-use reagent discs, serving primary care, urgent care, hospitals, specialty practices, government/military, and research customers globally via authorized distributors including Abbott and Sysmex.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersUnion City, United States
HQ citystring
Union City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
point-of-care diagnostics, blood chemistry analyzers, clinical chemistry panels, medical diagnostic devices, veterinary diagnostics
Industry2 codes
1Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
CodeHLAHAAANPrimaryYes
2Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
CodeHLAGAIADPrimaryNo
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Point-of-care blood chemistry diagnostics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Piccolo Xpress Analyzer Sales
TypeHardware Sales
Description

Sale of the Piccolo Xpress blood chemistry analyzer hardware to healthcare providers. The analyzer is a portable device that healthcare facilities purchase for point-of-care testing capabilities.

abaxis.com
2Reagent Disc Consumables
TypeTransaction Fee
Description

Recurring sales of single-use reagent discs that perform various chemistry panels (Basic Metabolic Panel, Lipid Panel, etc.). Discs must be refrigerated at 2-8°C with shelf life of 9-18 months. Replenishable consumable revenue model.

abaxis.com
3Reimbursable Panel Testing
TypeTransaction Fee
Description

Piccolo panels are reimbursable by most private insurers and government healthcare agencies in the US and other multi-payer markets, contributing to practice profitability.

abaxis.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Direct purchase through authorized distributors
ModelOtherBilling cadencePay-as-you-go
Notes

Sales of Piccolo Xpress Analyzer and Reagent Panels are managed by authorized distribution partners. Contact local distributor for pricing information.

abaxis.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Piccolo Xpress
Description

Point-of-care blood chemistry analyzer that delivers real-time diagnostic results using single-use reagent discs. The Piccolo Xpress enables healthcare providers to perform multi-chemistry panels with 100 microliters of whole blood, serum, or plasma in approximately 12 minutes.

abaxis.com
+2 more records
Core offering1 text field

Abaxis manufactures and sells the Piccolo Xpress, a compact point-of-care blood chemistry analyzer, along with proprietary single-use reagent discs. The system delivers lab-accurate multi-chemistry panel results from 100 microliters of whole blood, serum, or plasma in approximately 12 minutes, serving medical and veterinary care providers through a global authorized distributor network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Sample-to-panel results in approximately 12 minutes
+4 more records
Product overview1 text field

Abaxis (now part of Zoetis) offers the Piccolo Xpress point-of-care blood chemistry system, consisting of the Piccolo Xpress chemistry analyzer and 17 compatible single-use reagent panels. The Piccolo Xpress analyzer is a compact spectrophotometer/centrifuge that measures enzymatic chemistry reactions at 9 wavelengths to deliver lab-accurate results in approximately 12 minutes from a 100-microliter whole blood sample. The reagent discs contain all reagents and diluent necessary for complete multi-test chemistry panels. The system is CLIA-waived and supports data export to EMR/LIS systems via USB ports. The platform serves care providers across primary care, urgent care, hospitals, specialty care, government/military, and research settings.

Product and service5 records
1Piccolo Xpress Blood Analyzer
CategoryDiagnostic instrument hardware
Description

A compact point-of-care chemistry analyzer that delivers real-time blood chemistry diagnostic results using single-use reagent discs containing up to 17 chemistry tests per disc, with sample-to-panel results in approximately 12 minutes using only 100 microliters of whole blood. Uses patented spectrophotometry and centrifugation technology with built-in iQC quality control, and is CLIA-waived for many panels. Sold to healthcare providers and veterinarians through authorized distributors.

2Piccolo Reagent Panels
CategoryDiagnostic consumables
Description

Self-contained single-use reagent discs compatible with the Piccolo Xpress analyzer, offering 17 complete chemistry panels and 31 tests covering liver, kidney, metabolic function, lipids, and electrolytes. Each disc is self-contained, single-use, and refrigerated at 2-8°C with shelf life of 9-18 months, generating recurring consumable revenue. Includes specific panels such as Basic Metabolic Panel, Comprehensive Metabolic Panel, Lipid Panel, Hepatic Function Panel, Renal Function Panel, Electrolyte Panel, and MetLyte Plus CRP.

3Basic Metabolic Panel
CategoryDiagnostic consumables
Description

Single-use Piccolo reagent disc that performs the basic metabolic panel chemistry tests on whole blood, serum, or plasma using the Piccolo Xpress analyzer. CLIA-waived for use in non-laboratory point-of-care settings.

4Comprehensive Metabolic Panel
CategoryDiagnostic consumables
Description

Single-use Piccolo reagent disc that performs the comprehensive metabolic panel chemistry tests on whole blood, serum, or plasma using the Piccolo Xpress analyzer. CLIA-waived.

5Lipid Panel
CategoryDiagnostic consumables
Description

Single-use Piccolo reagent disc for lipid panel testing on the Piccolo Xpress analyzer. CLIA-waived for point-of-care use.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Abaxis is now a part of Zoetis. The Piccolo Xpress veterinary products are now available through ZoetisUS.com/dx. Zoetis acquired Abaxis to strengthen its global veterinary diagnostics position. Zoetis is a leading global animal health company.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Abbott's i-STAT system is the most established point-of-care blood chemistry analyzer globally, using single-use cartridges to deliver rapid results from whole blood. Notably, Abbott is also Abaxis's primary US distributor, making it both a direct competitor and a channel partner.

TypeDirect peer
Description

Nova Biomedical manufactures the StatStrip and pHOx lines of point-of-care blood gas and chemistry analyzers used in hospitals and clinics worldwide. Its single-use sensor strip technology for whole-blood testing is closely analogous to Abaxis's reagent-disc architecture.

TypeEmerging player
Description

EKF Diagnostics offers the QuikRead and DiaSpect point-of-care hemoglobin, HbA1c, and chemistry analyzers. While smaller and with a more focused menu, EKF competes in primary care POC chemistry and provides comparable single-use consumable economics.

TypeBroad incumbent
Description

Roche offers the cobas family of point-of-care and central-lab analyzers including the Accu-Chek line. As the world's largest diagnostics company, Roche competes with Abaxis across hospital POC chemistry and primary care settings, while also serving as an IVD reagent manufacturer.

TypeDirect peer
Description

Werfen's GEM Premier series delivers point-of-care blood gas, chemistry, and critical-care testing in hospitals. Werfen is also an Abaxis distributor for Spain and the Iberian Peninsula, making it both a competitor and channel partner in Europe.

TypeDirect peer
Description

HORIBA Medical produces the Microsemi and ABX series of compact hematology and clinical chemistry analyzers. Its POC-focused products target the same small-footprint, near-patient diagnostic niche as the Piccolo Xpress.

TypeDirect peer
Description

Randox manufactures the Evidence and Discovery analyzers offering comprehensive blood chemistry and immunoassay panels at the point of care. Its single-use biochip arrays are comparable in concept to Piccolo's reagent discs.

TypeBroad incumbent
Description

Formed from the merger of Quidel and Ortho Clinical Diagnostics, QuidelOrtho offers the Triage and Vitros lines of point-of-care immunoassay and chemistry analyzers. The Vitros series competes directly with Piccolo Xpress in hospital and reference lab settings.

TypeBroad incumbent
Description

Sysmex is a global leader in hematology and clinical chemistry analyzers, distributing the Piccolo Xpress across multiple European countries while also offering competing POC and central-lab chemistry platforms. Its dual role as channel partner and competitor mirrors the Abbott relationship.

TypeBroad incumbent
Description

Siemens Healthineers offers the RAPIDPoint and epoc blood gas/chemistry analyzers as part of a broad diagnostics portfolio spanning central lab, immunoassay, and imaging. The POC systems compete directly with Piccolo Xpress in hospital satellite labs and ED settings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Abaxis

Point-of-care blood chemistry diagnosticsabaxis.com

Abaxis (Zoetis subsidiary) manufactures the Piccolo Xpress point-of-care blood chemistry analyzer and proprietary single-use reagent discs, serving primary care, urgent care, hospitals, specialty practices, government/military, and research customers globally via authorized distributors including Abbott and Sysmex.

What Abaxis does

Abaxis develops, manufactures, and distributes point-of-care blood chemistry diagnostic systems, with the Piccolo Xpress analyzer as its flagship product. The platform combines spectrophotometry and centrifugal analysis to deliver multi-chemistry panel results from approximately 100 microliters of whole blood, serum, or plasma in roughly 12 minutes. At its core is a single-use, self-contained reagent disc that holds all reagents and diluent for a complete panel, paired with an integrated intelligent Quality Control (iQC) system that automatically validates each run. The company markets 17 reagent panels covering 31 tests spanning general and critical chemistry (basic metabolic, comprehensive metabolic, lipid, liver, kidney, electrolyte, and specialty panels), eleven of which are CLIA-waived for use outside traditional laboratory settings.

Abaxis serves a broad healthcare customer base across six verticals: primary care practices, urgent care centers, hospitals and integrated delivery networks, specialty care providers, government and military operations, and clinical research organizations. The company has historically operated an asset-light commercial model, selling Piccolo Xpress analyzers and reagent disc consumables exclusively through a global network of authorized distributors — including Abbott Point of Care as primary US distributor, Sysmex across multiple European markets, and country-specific distributors spanning North America, Europe, Asia-Pacific, the Middle East, and Africa. Revenue mechanics combine upfront analyzer hardware placement with recurring consumables revenue, supported by reimbursement from private insurers and government healthcare programs in multi-payer markets.

Abaxis was acquired by Zoetis in 2018 and now operates as a wholly-owned subsidiary within Zoetis's diagnostics business, with veterinary products redirected to ZoetisUS.com/dx while the human point-of-care franchise continues under the Abaxis brand through its existing distributor network. The firm was founded in 1989 and is headquartered in Union City, California, with a regional office in Garching, Germany. Current ownership is private; the company previously traded on NASDAQ under ABAX prior to the Zoetis acquisition.

Abaxis firmographics

Firmographics
Name
Abaxis
Legal name
Abaxis, Inc.
Website
https://abaxis.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Abaxis (Zoetis subsidiary) manufactures the Piccolo Xpress point-of-care blood chemistry analyzer and proprietary single-use reagent discs, serving primary care, urgent care, hospitals, specialty practices, government/military, and research customers globally via authorized distributors including Abbott and Sysmex.
Ownership category
akta.pro rank

Abaxis industry classification

Industry
Product category
Point-of-care blood chemistry diagnostics
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
akta.pro secondary industry
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD)

Keywords

  • Point-of-care diagnostics
  • Blood chemistry analyzers
  • Clinical chemistry panels
  • Medical diagnostic devices
  • Veterinary diagnostics

Where Abaxis is headquartered

Location

Headquarters

HQ city
Union City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Abaxis business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Piccolo Xpress Analyzer Sales: Sale of the Piccolo Xpress blood chemistry analyzer hardware to healthcare providers. The analyzer is a portable device that healthcare facilities purchase for point-of-care testing capabilities.
  2. Reagent Disc Consumables: Recurring sales of single-use reagent discs that perform various chemistry panels (Basic Metabolic Panel, Lipid Panel, etc.). Discs must be refrigerated at 2-8°C with shelf life of 9-18 months. Replenishable consumable revenue model.
  3. Reimbursable Panel Testing: Piccolo panels are reimbursable by most private insurers and government healthcare agencies in the US and other multi-payer markets, contributing to practice profitability.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goDirect purchase through authorized distributors

Go-to-market motion1 record

Distribution channels8 records

Marketing channels4 records

Abaxis product offering

Product offering

Core offering

Abaxis manufactures and sells the Piccolo Xpress, a compact point-of-care blood chemistry analyzer, along with proprietary single-use reagent discs. The system delivers lab-accurate multi-chemistry panel results from 100 microliters of whole blood, serum, or plasma in approximately 12 minutes, serving medical and veterinary care providers through a global authorized distributor network.

Product overview

Abaxis (now part of Zoetis) offers the Piccolo Xpress point-of-care blood chemistry system, consisting of the Piccolo Xpress chemistry analyzer and 17 compatible single-use reagent panels. The Piccolo Xpress analyzer is a compact spectrophotometer/centrifuge that measures enzymatic chemistry reactions at 9 wavelengths to deliver lab-accurate results in approximately 12 minutes from a 100-microliter whole blood sample. The reagent discs contain all reagents and diluent necessary for complete multi-test chemistry panels. The system is CLIA-waived and supports data export to EMR/LIS systems via USB ports. The platform serves care providers across primary care, urgent care, hospitals, specialty care, government/military, and research settings.

Differentiator

Problem solved

Functional benefit

Brands

  • Piccolo Xpress: Point-of-care blood chemistry analyzer that delivers real-time diagnostic results using single-use reagent discs. The Piccolo Xpress enables healthcare providers to perform multi-chemistry panels with 100 microliters of whole blood, serum, or plasma in approximately 12 minutes.
  • Piccolo
  • iQC (Intelligent Quality Control)

Products and services

  • Piccolo Xpress Blood Analyzer A compact point-of-care chemistry analyzer that delivers real-time blood chemistry diagnostic results using single-use reagent discs containing up to 17 chemistry tests per disc, with sample-to-panel results in approximately 12 minutes using only 100 microliters of whole blood. Uses patented spectrophotometry and centrifugation technology with built-in iQC quality control, and is CLIA-waived for many panels. Sold to healthcare providers and veterinarians through authorized distributors.
  • Piccolo Reagent Panels Self-contained single-use reagent discs compatible with the Piccolo Xpress analyzer, offering 17 complete chemistry panels and 31 tests covering liver, kidney, metabolic function, lipids, and electrolytes. Each disc is self-contained, single-use, and refrigerated at 2-8°C with shelf life of 9-18 months, generating recurring consumable revenue. Includes specific panels such as Basic Metabolic Panel, Comprehensive Metabolic Panel, Lipid Panel, Hepatic Function Panel, Renal Function Panel, Electrolyte Panel, and MetLyte Plus CRP.
  • Basic Metabolic Panel Single-use Piccolo reagent disc that performs the basic metabolic panel chemistry tests on whole blood, serum, or plasma using the Piccolo Xpress analyzer. CLIA-waived for use in non-laboratory point-of-care settings.
  • Comprehensive Metabolic Panel Single-use Piccolo reagent disc that performs the comprehensive metabolic panel chemistry tests on whole blood, serum, or plasma using the Piccolo Xpress analyzer. CLIA-waived.
  • Lipid Panel Single-use Piccolo reagent disc for lipid panel testing on the Piccolo Xpress analyzer. CLIA-waived for point-of-care use.

Quantifiable outcome

  • Sample-to-panel results in approximately 12 minutes
  • +4 more outcomes

Companies that use Abaxis

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Abaxis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Abaxis partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ZoetiscoreOthersAbaxis is now a part of Zoetis. The Piccolo Xpress veterinary products are now available through ZoetisUS.com/dx. Zoetis acquired Abaxis to strengthen its global veterinary diagnostics position. Zoetis is a leading global animal health company.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Abaxis competitors and assessment

Company assessment

Direct peers

  • Abbott Point of Care: Abbott's i-STAT system is the most established point-of-care blood chemistry analyzer globally, using single-use cartridges to deliver rapid results from whole blood. Notably, Abbott is also Abaxis's primary US distributor, making it both a direct competitor and a channel partner.
  • Nova Biomedical: Nova Biomedical manufactures the StatStrip and pHOx lines of point-of-care blood gas and chemistry analyzers used in hospitals and clinics worldwide. Its single-use sensor strip technology for whole-blood testing is closely analogous to Abaxis's reagent-disc architecture.
  • Werfen: Werfen's GEM Premier series delivers point-of-care blood gas, chemistry, and critical-care testing in hospitals. Werfen is also an Abaxis distributor for Spain and the Iberian Peninsula, making it both a competitor and channel partner in Europe.
  • HORIBA Medical: HORIBA Medical produces the Microsemi and ABX series of compact hematology and clinical chemistry analyzers. Its POC-focused products target the same small-footprint, near-patient diagnostic niche as the Piccolo Xpress.
  • Randox Laboratories: Randox manufactures the Evidence and Discovery analyzers offering comprehensive blood chemistry and immunoassay panels at the point of care. Its single-use biochip arrays are comparable in concept to Piccolo's reagent discs.

Emerging players

  • EKF Diagnostics: EKF Diagnostics offers the QuikRead and DiaSpect point-of-care hemoglobin, HbA1c, and chemistry analyzers. While smaller and with a more focused menu, EKF competes in primary care POC chemistry and provides comparable single-use consumable economics.

Broad incumbents

  • Roche Diagnostics: Roche offers the cobas family of point-of-care and central-lab analyzers including the Accu-Chek line. As the world's largest diagnostics company, Roche competes with Abaxis across hospital POC chemistry and primary care settings, while also serving as an IVD reagent manufacturer.
  • QuidelOrtho: Formed from the merger of Quidel and Ortho Clinical Diagnostics, QuidelOrtho offers the Triage and Vitros lines of point-of-care immunoassay and chemistry analyzers. The Vitros series competes directly with Piccolo Xpress in hospital and reference lab settings.
  • Sysmex: Sysmex is a global leader in hematology and clinical chemistry analyzers, distributing the Piccolo Xpress across multiple European countries while also offering competing POC and central-lab chemistry platforms. Its dual role as channel partner and competitor mirrors the Abbott relationship.
  • Siemens Healthineers: Siemens Healthineers offers the RAPIDPoint and epoc blood gas/chemistry analyzers as part of a broad diagnostics portfolio spanning central lab, immunoassay, and imaging. The POC systems compete directly with Piccolo Xpress in hospital satellite labs and ED settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Abaxis social profiles

Digital presence

Abaxis compliance and trust

Trust signal

Compliance1 record

Abaxis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Abaxis leadership team

Management profile

Number of profiles

Abaxis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Abaxis M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abaxis

What does Abaxis do?

Abaxis manufactures and sells the Piccolo Xpress, a compact point-of-care blood chemistry analyzer, along with proprietary single-use reagent discs. The system delivers lab-accurate multi-chemistry panel results from 100 microliters of whole blood, serum, or plasma in approximately 12 minutes, serving medical and veterinary care providers through a global authorized distributor network.

Is Abaxis a public or private company?

Abaxis is a private company. It is classified as corporate owned and is currently operating.

When was Abaxis founded?

Abaxis was founded in 1995. It employs 5,001 to 10,000 people.

Where is Abaxis based?

Abaxis is headquartered in Union City, United States, in the North America region.

How does Abaxis make money?

Three revenue lines are on record. Piccolo Xpress Analyzer Sales are the primary driver. The others are reagent Disc Consumables and reimbursable Panel Testing.

Who are Abaxis's main competitors?

Direct peers on record are Abbott Point of Care, Nova Biomedical, Werfen, HORIBA Medical and Randox Laboratories. EKF Diagnostics is listed as an emerging player. Broad incumbents are Roche Diagnostics, QuidelOrtho, Sysmex and Siemens Healthineers.

Does Abaxis have an API?

No public API is recorded for Abaxis.

What industry is Abaxis in?

Abaxis's product category is Point-of-care blood chemistry diagnostics. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAGAIAD, Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comImmunoassay Veterinary Diagnostic Kits Market Projections 2025-2032: Key Trends, Opportunities, and Growth Factors in New Report | Idexx Laboratories • Neogen Corporation • Zoetis • AbaxisThe article reports on the release of a market research report by Coherent Market Insights analyzing the immunoassay veterinary diagnostic kits market from 2025 to 2032. The report details market segmentation, key players, geographic distribution, and strategic analysis, aimed at guiding stakeholders about industry trends and growth opportunities.openPR.comVeterinary Diagnostic Kit Market Booming with Rapid Growth Through 2032: Idexx Laboratories • Zoetis • Neogen Corporation • AbaxisCoherent Market Insights released a research report forecasting the veterinary diagnostic kit market to grow through 2032, covering industry trends, competitive landscape, and regional analysis. The report identifies major players including Idexx Laboratories, Zoetis, Neogen Corporation, and Abaxis as key entities in this expanding sector. It provides detailed segmentation by animal type and region to assist investors and strategists in evaluating market opportunities.TracxnTop startups in Point of Care Diagnostics in United States (Nov, 2025)Several startups in the Point of Care Diagnostics sector have been highlighted, including Exo, LumiraDx, EchoNous, and Abaxis, all based in the United States. Notably, these companies are involved in developing advanced medical diagnostic technologies, with significant funding raised in recent years; for instance, Exo has secured $428 million in total funding since its founding in 2015.GlobeNewswireVeterinary Diagnostics Market Anticipated to Hit USD 12.9 Billion by 2032, Signifying Impressive GrowthThe veterinary diagnostics market is projected to grow from USD 6 billion in 2022 to USD 12.9 billion by 2032, a CAGR of 8.2%. Zoetis acquired Abaxis and IDEXX launched a blood analyser, while North America is expected to lead due to high pet ownership.PR NewswireGlobal Veterinary Infectious Diseases Diagnostics Market Analysis 2020-2025, Featuring Key Players Abaxis, Zoetis Services LLC and Agrolabo S.p.AResearchAndMarkets.com has added a new market analysis report on the Veterinary Infectious Diseases Diagnostics Market, projecting growth to US$5.369 billion by 2025 at a CAGR of 7.98%. The report highlights drivers such as increasing disease prevalence in livestock and companion animals, with molecular diagnostics expected to gain significant market share.PR NewswireWeissLaw LLP Investigates Abaxis Inc.WeissLaw LLP is investigating the Board of Directors of Abaxis Inc. for potential breaches of fiduciary duty regarding its proposed acquisition by Zoetis Inc., which offers shareholders $83.00 per share. The investigation was prompted by analyst target prices reaching $90.00 and recent positive financial results from Abaxis, suggesting the offer may not maximize shareholder value.PR NewswireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Abaxis, Inc.Rowley Law PLLC announced an investigation into potential breach of fiduciary duty claims against Abaxis, Inc. and its board of directors regarding the proposed acquisition by Zoetis Inc. Shareholders of Abaxis will receive $83.00 per share in a transaction valued at approximately $2 billion, expected to close before the end of 2018.PR NewswireAbaxis (ABAX) Alert: Johnson Fistel Investigates Proposed Sale of Abaxis, Inc.; Are Shareholders Getting a Fair Deal?Shareholder rights law firm Johnson Fistel announced on May 16, 2018 that it has launched an investigation into whether the board of Abaxis, Inc. breached its fiduciary duties in connection with the proposed sale to Zoetis Inc. Under the definitive merger agreement, Zoetis will pay $83 in cash per Abaxis share outstanding. The investigation focuses on whether the board adequately pursued alternatives to the acquisition and obtained the best possible price for shareholders, particularly given the company's projected earnings growth.PR NewswireAbaxis, Inc. to Present at the Bank of America Merrill Lynch 2018 Health Care Conference and the UBS Global Healthcare ConferenceAbaxis, Inc. announced that its management will present at the Bank of America Merrill Lynch 2018 Health Care Conference on May 16, 2018, and the UBS Global Healthcare Conference on May 22, 2018. The presentations will be made by Clint Severson, the CEO, and Ross Taylor, the CFO, at the respective conferences held in Las Vegas and New York City. These events are intended to highlight Abaxis as a leader in point-of-care diagnostics in the health care sector.PR NewswireAbaxis To Report Fourth Quarter And Fiscal Year 2018 Financial Results On Thursday, April 26, 2018Abaxis, Inc. has scheduled a conference call for April 26, 2018, to discuss its financial results for the fourth quarter and fiscal year 2018, which ended on March 31, 2018. The call will occur at 4:15 p.m. ET, and financial results will be reported after market close on the same day. This reporting is part of Abaxis's ongoing commitment to transparency and communication with its investors.